Production of monoclonal antibodies for rapid diagnostic kitsProduct of BMR

Bio Matrix Research (BMR) was founded with the objective of developing advanced systems for producing high-quality monoclonal antibodies. After many years of dedicated research and development work and challenges, we have successfully developed the original screening method for producing a wide range of monoclonal antibodies suitable for use in rapid diagnostic test (RTDs) kits. Products & Services

Learn more about BMR

Company Overview